GlobeImmune Revenue, Profits - GBIM Annual Income Statement

Add to My Stocks
$0.57 $0 (0%) GBIM stock closing price Jun 20, 2018 (Closing)

Looking at financial statements, along with the GlobeImmune stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $6.45M for 2015 impacts the GBIM stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2015 is $6.45M and has increased from $5.96M year on year as is evident when you compare the latest figures in the latest GlobeImmune profit and loss statement with those of the prior corresponding period. Also see GlobeImmune assets and GlobeImmune free cash flow for a complete valuation of GBIM stock.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec2015201420132012
GlobeImmune Revenues or Net Sales
6.45M5.96M22.51M14.64M
Cost Of Goods Sold (COGS)2.64M4.99M9.02M10.03M
GlobeImmune Gross Profit
3.8M-13.49M4.6M
Research & Development Expense1.83M2.22M1.86M1.7M
Selling General & Admin Expense4.55M4.27M3.17M5.94M
Income Before Depreciation Depletion Amortization-2.57M-5.52M8.45M-3.04M
Depreciation Depletion Amortization----
Non Operating Income--6.55M1.9M1.95M
Interest Expense-3.89M--
GlobeImmune Pretax Income
-2.76M-16.26M9.59M-2.01M
Provision for Income Taxes----
MinorityInterest----
Investment Gains Losses----
Other Income----
Income Before Extraordinaries & Disc Operations-2.76M-16.26M9.47M-2.01M
Extraordinary Items & Discontinued Operations----
GlobeImmune Profit/ Loss (Net Income)
-2.76M-16.26M9.47M-2.01M
Average Shares used to compute Diluted EPS5.75M2.92M2.95M-
Average Shares used to compute Basic EPS5.75M2.92M2.95M-
Income Before Nonrecurring Items-2.77M-11.57M-3.41M-
Income from Nonrecurring Items--4.69M--
GlobeImmune Earnings Per Share Basic Net
-0.48-8.042.60-
GlobeImmune Earnings Per Share Diluted Net
-0.48-8.042.60-
EPS Diluted Before Nonrecurring Items-0.48-6.432.60-
Preferred Dividends Acc Pd----
Dividends Common----
Dividend Per Share Common0.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

It is very helpful to read a report on GlobeImmune stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the GlobeImmune revenue chart, as is the case with GlobeImmune indicates a growing business. One needs to compare the YoY topline or sales growth of GBIM stock with its peers like ACUR stock and PARNF stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-2.76M for GlobeImmune for 2015. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The GBIM financials along with GlobeImmune historical stock prices provide a lot of details about the firm.

GlobeImmune Income Statement - Key Financial Ratios